SCI时时刷

search
Tyrosine kinase inhibitors in cancers: Treatment optimization – Part II
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 890d0a2fdc2b15fb-...
Safety of immune checkpoint inhibitors: An updated comprehensive disproportionality analysis and meta-analysis
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 890d0a298cc1cef1-...
A Landscape of Methodology and Implementation of Adaptive Designs in Cancer Clinical Trials
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 88ffc40ed958f97b-...
Emerging role of circulating cell-free RNA as a non-invasive biomarker for hepatocellular carcinoma
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 88ffc3aeadb1cfac-...
Rediscovering immunohistochemistry in lung cancer
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 88f28d342ad1fabe-...
Navigating the Complexity of PI3K/AKT Pathway in HER-2 Negative Breast Cancer: Biomarkers and Beyond
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 88f28d2dca5596b7-...
A viable remedy for overcoming resistance to anti-PD-1 immunotherapy: fecal microbiota transplantation
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 88f28d149be3237a-...
Targeting Pediatric Solid Tumors in the New Era of RNA Therapeutics
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 88e5548fd90baab2-...
The relationship between LDH and GLIM criteria for cancer cachexia: Systematic review and meta-analysis
The relationship between LDH and GLIM criteria for cancer cachexia: Systematic review and meta-analysis
Donald C McMillan PhD, OBE. As Professor of Surgical Science at the University of Glasgow, work carried out by Professor M...
Mapping inter-professional collaboration in oncogenetics: Results from a scoping review
Mapping inter-professional collaboration in oncogenetics: Results from a scoping review
Volume 199, July 2024, 104364Author links open overlay panel, , , , , , , , Highlights•Collaboration appears to be mostly ...
Tyrosine Kinase Inhibitors in Cancers: treatment optimization – Part I
Tyrosine Kinase Inhibitors in Cancers: treatment optimization – Part I
In the 20 years following the introduction of imatinib, many tyrosine kinase inhibitors (TKI) have been developed and Food...
Emerging Targeted Therapies and Strategies to Overcome Resistance in Biliary Tract Cancers
Emerging Targeted Therapies and Strategies to Overcome Resistance in Biliary Tract Cancers
Although biliary tract cancers (BTC) remain a rare tumor type, there has been a rising incidence rate over the last decade...
Combining Immunotherapy and Radiation therapy in Gastrointestinal Cancers: A Review
Combining Immunotherapy and Radiation therapy in Gastrointestinal Cancers: A Review
Hans Prenen MD, PhD, heads Medical Oncology at University Hospital Antwerp, directs the University Center for Clinical Res...
A review concerning the breast cancer-related tumour microenvironment
A review concerning the breast cancer-related tumour microenvironment
Manuel Alfonso Patarroyo obtained both his M.D. and Dr.Sc. degrees from the Universidad Nacional de Colombia. He is curren...
State of the art: targeting microsatellite instability in gastrointestinal cancers
State of the art: targeting microsatellite instability in gastrointestinal cancers
Prof Marco Gerlinger, MD FRCP. Clinician Scientist at the Barts Cancer Institute, London, with an interest in mechanisms o...
Dostarlimab: Review on success story and clinical trials
Dostarlimab: Review on success story and clinical trials
In recent years, the evolutionary development of immune checkpoint inhibitor (ICI) antibodies targeting cytotoxic programm...
Unlocking Hope: Anti-VEGFR inhibitors and their potential in glioblastoma treatment
Unlocking Hope: Anti-VEGFR inhibitors and their potential in glioblastoma treatment
Glioblastoma multiforme (GBM) is a primary malignant brain cancer that occurs in all parts of the central nervous system, ...
Thromboembolic risk in prostate cancer patients treated with PARP inhibitors: A systematic review and meta-analysis
Thromboembolic risk in prostate cancer patients treated with PARP inhibitors: A systematic review and meta-analysis
DNA replication is a fine work that requires a high degree of accuracy to prevent errors. However, mistakes can occur duri...
Brain Metastasis: an insight into novel molecular targets for theranostic approaches
Brain Metastasis: an insight into novel molecular targets for theranostic approaches
Célia Gomes, Ph.D., is a senior researcher at the Coimbra Institute for Clinical and Biomedical Research - Faculty of Medi...
Interactions between platelets and the cancer immune microenvironment
Interactions between platelets and the cancer immune microenvironment
Cancer, characterized by its high incidence and low cure rate, is the leading cause of mortality in both China and develop...
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways
Over the last two decades, advances in basic science have been moving oncology practice towards a more personalized, molec...
Immunotherapy and targeted therapy as first-line treatment for advanced gastric cancer
Immunotherapy and targeted therapy as first-line treatment for advanced gastric cancer
Gastric cancer remains a critical global health issue, ranking as the third leading cause of cancer-related mortality (Smy...